Prospective Study of Body Mass Index and Risk of Stroke in Apparently Healthy Women
http://www.100md.com
循环学杂志 2005年第4期
the Division of Preventive Medicine (T.K., J.M.G., K.M.R., N.R.C., J.E.M., J.E.B.), Division of Aging (T.K., J.M.G., J.E.B.)
Division of Cardiovascular Disease (J.M.G.)
Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
Department of Epidemiology (T.K., N.R.C., J.E.M., J.E.B.)
Harvard School of Public Health
Massachusetts Veterans Epidemiology Research and Information Center (J.M.G.), Boston VA Healthcare System
Department of Ambulatory Care and Prevention (J.E.B.), Harvard Medical School
Department of Neurology (C.S.K.), Boston University Medical Center, Boston, Mass.
Abstract
Background— Obesity is an escalating pandemic in the United States, and its association with coronary heart disease is well understood. Several studies have found positive associations between body mass index (BMI) and stroke in men, but the association with stroke and its subtypes is less clear in women.
Methods and Results— This was a prospective cohort study among 39 053 women participating in the Women’s Health Study. BMI was measured as self-reported weight (in kilograms) divided by height (in meters) squared. Incident stroke was self-reported and confirmed by medical record review. We used the Cox proportional hazards model to evaluate the association between BMI and stroke. After a mean follow-up of 10 years, a total of 432 strokes (347 ischemic, 81 hemorrhagic, and 4 undefined) occurred. We found a statistically significant trend for increased risk of total and ischemic stroke across 7 BMI categories. With World Health Organization criteria, women who were obese (BMI 30 kg/m2) had hazard ratios of 1.50 (95% CI 1.16 to 1.94) for total stroke, 1.72 (95% CI 1.30 to 2.28) for ischemic stroke, and 0.82 (95% CI 0.43 to 1.58) for hemorrhagic stroke compared with women with BMI <25 kg/m2. Additional control for history of hypertension, diabetes, and elevated cholesterol substantially attenuated the hazard ratios for total and ischemic stroke. There was no effect modification for age, exercise, or smoking.
Conclusions— In this large prospective cohort study among women, BMI was a strong risk factor for total and ischemic stroke but not for hemorrhagic stroke. The association was highly mediated by hypertension, diabetes, and elevated cholesterol.
Key Words: obesity ; stroke ; epidemiology ; women
Introduction
Overweight and obesity represent an emerging threat to public health,1–3 affecting nearly 59 million adults in the United States alone.4 In addition, and perhaps more worrisome, the percentage of young people who are overweight has more than doubled over the last 20 years.4,5 Approximately 300 000 deaths each year in the United States are estimated to be attributable to obesity,6 and the economic burden is enormous.4 Overweight and obesity are well-documented risk factors for a variety of diseases,2 including coronary heart disease, hypertension, type 2 diabetes mellitus, osteoarthritis, and certain cancers.7,8
There is increasing evidence that obesity is a risk factor for ischemic stroke.9–14 Despite this, excess weight has not been recognized as an established risk factor for stroke15 and generally has not been included in the overall estimation of stroke risk.16–18 In addition, the association between body mass index (BMI) and hemorrhagic stroke is less clear.9,10,12,14,19–21 Stroke remains a leading cause of severe disability and premature death in the United States and other Western countries. Effective therapies for the treatment of acute ischemic stroke only are used in a small number of patients22 and do not help to completely reverse the impaired function of affected brain areas. Thus, the identification of modifiable lifestyle factors remains critical for stroke prevention. We aimed to evaluate the association between BMI and total stroke, ischemic stroke, and hemorrhagic stroke in more than 39 000 apparently healthy female health professionals participating in the Women’s Health Study (WHS).
Methods
Participants
Study individuals were all participants in the WHS, a recently completed randomized, double-blind, placebo-controlled trial that tested the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among apparently healthy women. The design and methods of the WHS have been described in detail previously.23,24 Briefly, a total of 39 876 US female health professionals aged 45 years or older at baseline in beginning of 1993 and without a history of cardiovascular disease, cancer, or other major illnesses were randomly assigned to 1 of 4 treatment groups: active aspirin (100 mg on alternate days), active vitamin E (600 IU on alternate days), both active agents, or both placebos. Baseline information was self-reported and was collected by a mailed questionnaire that asked about a large number of cardiovascular risk factors and lifestyle variables. Twice in the first year and annually thereafter, participants were sent follow-up questionnaires that asked about study compliance, study outcomes (including stroke), personal characteristics, medical history, and health habits during the study period. For the present analysis, we included follow-up information from the time of randomization through March 31, 2004. As of this date, follow-up was 96% complete. The Institutional Review Board of the Brigham and Women’s Hospital approved the study.
Assessment of BMI
Participants reported their height and weight on the baseline questionnaire. On the 24-, 36-, 60-, 72-, and 108-month questionnaires, participants were asked again to report their weight, and on the 72- and 108-month questionnaires, they were asked to report their height again. BMI was calculated as self-reported weight in kilograms divided by height in meters squared (kg/m2). We used the baseline height information to calculate BMI for all but the 72- and 108-month time points. We categorized BMI into a priori categories of <20.0, 20.0 to 22.9, 23.0 to 24.9, 25.0 to 26.9, 27.0 to 29.9, 30.0 to 34.9, and 35.0 kg/m2. We further evaluated BMI on the basis of the World Health Organization (WHO) categories of <25 (normal weight), 25 to 29.9 (overweight), and 30 kg/m2 (obese), as well as a continuous term.
Ascertainment of Stroke
Participants who reported a stroke on a follow-up questionnaire were asked for permission to review their medical records. A diagnosis of stroke was confirmed only after review of the medical records by an End Points Committee of physicians that included a neurologist. A nonfatal stroke was defined as a focal neurological deficit of sudden onset and vascular mechanism that lasted >24 hours. Cases of fatal stroke were documented by evidence of a cerebrovascular mechanism obtained from all available sources, including death certificates and hospital records. Stroke was classified according to the criteria established by the National Survey of Stroke25 as ischemic stroke, hemorrhagic stroke, and unknown subtype. The interobserver agreement of the classification of stroke and its major subtypes in the WHS was excellent.26
Statistical Analysis
Of the 39 876 randomized participants, we excluded 820 women with missing information on weight or height on the baseline questionnaire. We additionally excluded 3 participants who reported a stroke before the receipt of the baseline questionnaire, which left a total of 39 053 women for the present study.
We compared the characteristics of participants with respect to baseline BMI categories using direct standardization to adjust categorical variables for age in 5-year increments. We used the Cox proportional hazards model27 to analyze the association between BMI and the incidence of stroke. We calculated age- and multivariable-adjusted hazard ratios (HRs) and their 95% CIs for total (including ischemic, hemorrhagic, and undefined stroke cases), ischemic, and hemorrhagic (including subarachnoid and intracerebral hemorrhage) strokes. We made a distinction in the multivariable models between variables that were considered potential confounders and those considered potential biological intermediate variables in the association between BMI and stroke risk. In the first multivariable model (model 1), we controlled for age (quadratic term), alcohol consumption (<1 drink per week, 1 to 6 drinks per week, 1 drink per day), smoking (never, past, current <15 cigarettes per day, current 15 cigarettes per day), physical activity (1 time per week, 2 to 3 times per week, 4 times per week), and postmenopausal hormone use. We considered other potential confounding variables including ethnicity, oral contraceptive use, and education, which did not lead to substantially different results. We then considered 3 potential biological mediators: history of hypertension (defined as self-reported systolic blood pressure of 140 mm Hg or diastolic blood pressure 90 mm Hg, or report of diagnosis of hypertension by a physician), history of diabetes, and history of elevated cholesterol (240 mg/dL). In the second multivariable model (model 2), we controlled for all variables in model 1 plus hypertension at baseline. In the third model, we then additionally controlled for history of diabetes and elevated cholesterol at baseline. We decided a priori not to control for randomized treatment assignment. Because randomization in this large trial was successful,24 randomized treatment assignment is not associated with BMI. Consequently, by definition, randomized treatment assignment cannot be a confounder of the association between BMI and stroke.
Our primary analysis was to evaluate the association between baseline BMI and risk of total, ischemic, and hemorrhagic stroke. As a secondary approach, we updated the information on BMI by incorporating weight change over time. We evaluated effect modification by age (<60 versus 60 years), exercise frequency (<1 times per week versus 1 times per week), and smoking status (current versus never/past). We used the likelihood ratio test to test for statistical significance. All probability values were 2 tailed, and we considered P<0.05 as statistically significant.
Results
When we used WHO categories for BMI, women in the obese category (30 kg/m2) had multivariable-adjusted (model 1) HRs of 1.50 (95% CI 1.16 to 1.94) for total stroke, 1.72 (95% CI 1.30 to 2.28) for ischemic stroke, and 0.82 (95% CI 0.43 to 1.58) for hemorrhagic stroke compared with women with BMI <25 kg/m2. After we additionally controlled for history of hypertension, diabetes, and elevated cholesterol, the risks of total and ischemic stroke were attenuated to 1.04 (95% CI 0.80 to 1.37) for total stroke and 1.15 (95% CI 0.85 to 1.55) for ischemic stroke.
When we evaluated BMI as a continuous variable, a 1-unit increase in BMI was associated with a 4% increase in total stroke (multivariable [model 1]-adjusted HR 1.04, 95% CI 1.02 to 1.06) and a 5% increase for ischemic stroke (HR 1.05, 95% CI 1.03 to 1.07) but had no association with hemorrhagic stroke (HR 0.99, 95% CI 0.94 to 1.04). These relative risks for total and ischemic stroke were also attenuated after we controlled for history of hypertension, diabetes, and elevated cholesterol: 1.01 (95% CI 0.99 to 1.03) for total stroke and 1.02 (95% CI 0.99 to 1.04) for ischemic stroke.
When we updated the information on BMI over the course of follow-up, the results were similar in direction compared with the association between baseline BMI and risk of stroke and stroke subtypes. After adjustment for potential confounders (model 1), women with BMI values 35 kg/m2 had HRs of 1.66 (95% CI 1.01 to 2.71) for total stroke, 1.89 (95% CI 1.09 to 3.26) for ischemic stroke, and 0.79 (95% CI 0.23 to 2.65) for hemorrhagic stroke. As before, the HRs for total and ischemic stroke were attenuated when we additionally controlled for history of hypertension, diabetes, and elevated cholesterol, with HRs of 1.02 (95% CI 0.62 to 1.69) for total stroke and 1.10 (95% CI 0.63 to 1.94) for ischemic stroke.
Discussion
In this large prospective cohort study of >39 000 apparently healthy women, BMI was strongly associated with total and ischemic stroke but not with hemorrhagic stroke. We found a statistically significant trend across BMI categories for total and ischemic stroke and found significant increased risks for ischemic stroke beginning with BMI values 27.0 kg/m2 that steadily increased with higher BMI. Women with BMI 35 kg/m2 had a 2-fold increase in the risk of total stroke and an almost 3-fold increase in the risk of ischemic stroke compared with women with BMI <20 kg/m2. When WHO criteria were used, women who were obese (BMI 30 kg/m2) had a 1.5-fold increase in the risk of total stroke and a 1.7-fold increase in the risk of ischemic stroke compared with women with BMI <25 kg/m2. The association between BMI and total and ischemic stroke was strongly mediated by history of hypertension, diabetes, and elevated cholesterol. The association between BMI and stroke was not modified by age, smoking status, or exercise.
Over the last 2 decades, the association between obesity and stroke among women has been inconsistent, with some studies showing a positive association,11,12,28–30 and others showing no association.31–33 Data from the Nurses’ Health Study showed similar associations as in the present study and found a >2-fold increase in the risk of ischemic stroke and 1.6-fold increase in the risk for total stroke among women with BMI 32 kg/m2 compared with women with BMI <21 kg/m2.12 As in the present study, inclusion of hypertension, diabetes, and elevated cholesterol led to substantial attenuation of the risk estimates. There was also a suggestion of an inverse association between BMI and hemorrhagic stroke that also did not reach statistical significance. Similar to the present findings, the highest risk for hemorrhagic stroke was seen among women in the leanest BMI category. The study further evaluated weight change and found increased risk for total and ischemic stroke but not for hemorrhagic stroke among women who gained >11 kg.12 Studies that found no association between obesity and stroke may have been limited by small size32 or may have controlled for the potential biological mediator of hypertension.31,33
In men, a number of studies support an association between BMI and increased risk of stroke.9,10,21,34 A recent population-based study from G;teborg, Sweden, found a 2-fold increase in the risk for total, ischemic, and undetermined stroke for men with BMI >30 kg/m2 compared with men with BMI of 20.0 to 22.5 kg/m2.9 No association was observed between BMI and hemorrhagic stroke. Because that study showed a strong association between BMI and undetermined stroke, it is possible that some of these cases were in fact hemorrhagic strokes and that the association between BMI and hemorrhagic stroke was thus underestimated. Data from the Physicians’ Health Study showed a significant increase in the risk of total, ischemic, and hemorrhagic stroke with increasing BMI.10 Men with BMI 30 kg/m2 had a >2-fold risk increase for all stroke types. In both studies, the increased risk for total and ischemic stroke, although attenuated, remained statistically significant when additionally controlled for hypertension, diabetes, and elevated cholesterol.
The association between obesity and hemorrhagic stroke remains unclear. The present study is consistent with findings of others that showed an increased risk of hemorrhagic stroke among the lean.12,14,19 Other studies, however, found no association9,20,21 or an increased risk with increasing BMI.10 The fact that the incidence of hemorrhagic stroke is higher in Asian populations has led to the hypothesis that low cholesterol, in addition to lean body weight, may be associated with increased risk of hemorrhagic strokes.20,35 The low numbers of hemorrhagic strokes in most of the studies may explain in part the uncertainty with regard to the association between BMI and hemorrhagic stroke. Future studies are needed to determine whether lean BMI and/or low cholesterol or other factors are important contributors to hemorrhagic stroke.
There is an ongoing discussion about the best measure of obesity for stroke prediction.11,30,32,36 A report from the Northern Manhattan Stroke Study suggested that abdominal obesity, as measured by the waist-to-hip ratio, was a stronger predictor than BMI and had a greater effect among younger individuals.11 In that study, however, obesity was evaluated at the time of the stroke, which may indicate that abdominal obesity may be a better short-term predictor than BMI. Nevertheless, obesity is a strong risk factor for total and ischemic stroke regardless of the measure used. Whether more detailed information on body fat distribution will lead to better prediction of stroke currently remains unclear.
Obesity is a strong risk factor for the development of hypertension,37 diabetes,38 and elevated cholesterol.39 In virtually all studies that have evaluated the association between obesity and ischemic stroke, hypertension, diabetes, and elevated cholesterol were biological mediators.9,10,12,14,36 This, however, should not downplay the importance of obesity as a primary risk factor for stroke. To the contrary, because obesity has such a strong influence on hypertension and diabetes, obesity may be the biggest overall contributor to stroke occurrence. In some studies, a statistically significant excess risk for stroke remained even after controlling for hypertension, diabetes, and elevated cholesterol.9–11 In a recent large, population-based study from Malm;, Sweden among normotensive men and women, BMI was a statistically significant and independent predictor for stroke.40 Furthermore, the risks of excessive body fat for stroke can be obscured by a history of cigarette smoking and thinness associated with deteriorating health.41
In addition to the established mechanisms by which BMI affects stroke risk such as hypertension and diabetes, other mechanisms may be associated with the increased risk. Some investigators have proposed that an increase in prothrombotic factors observed among overweight and obese individuals may contribute to their increased risk for ischemic events.42–44 Increased levels of C-reactive protein in overweight and obese individuals45 may also play a role in their increased risk of stroke,46 because an association between increased levels of inflammatory markers and risk of ischemic stroke has been documented47,48; however, the biological interrelationship between obesity, inflammatory markers, and ischemic stroke risk has yet to be determined.
The present study has several strengths, including the prospective method of data collection, the large size of the study population, the large number of incident strokes, the high rate and length of follow-up, and the homogeneous nature of WHS participants, which reduces potential confounding by access to medical care and other socioeconomic factors. On each of the follow-up questionnaires, WHS participants were asked specifically about stroke and transient ischemic attacks. Because stroke was a major end point of the WHS trial, all efforts were made to obtain the relevant medical records, and an experienced End Points Committee confirmed stroke cases only after review of these records. In addition, the interobserver agreement in the classification of stroke was excellent.26 We further ran several different models, including time-varying models, to update the most recent exposure information, used different cutpoints of BMI, and evaluated potential biological mediators and effect modifiers.
Several limitations should be considered when evaluating the present results. First, information on body weight and height, as well as on all potential confounders, was self-reported, and thus nondifferential misclassification is possible. Participants of the WHS, however, were all health professionals, who are known to accurately report information regarding lifestyle factors and health status. Specifically, self-reported and directed measured weight were highly correlated (r=0.96) in another comparable cohort of female health professionals.49 In addition, nondifferential misclassification in a prospective study most likely would lead to an underestimation of the association between BMI and stroke. We have no reason to believe that a significant number of participants did not report a stroke event and particularly no reasoning that such potential underreporting would be differential with regard to BMI status. Second, because participants in the WHS were all health professionals who participated in a randomized trial, and the vast majority (94.9%) of them were white, the present results may not necessarily be extrapolated to other populations; however, we have no a priori basis for believing that the biological mechanisms by which BMI may lead to stroke differ in the WHS cohort compared with other populations. In addition, the relative measures of effect for a wide variety of cardiovascular risk factors have been similar to those seen in other studies. Because women participating in the WHS were somewhat leaner than the general population, we may have underestimated the risk of heavier populations. Finally, as with all observational studies, residual and unmeasured confounding remains an alternative explanation for our findings, despite adjustment for many potential confounders.
In conclusion, our study indicates that obesity is associated with increased risk of total and ischemic stroke. This was not modified by age, smoking, or exercise and was strongly mediated by hypertension, diabetes, and elevated cholesterol, which may be biological intermediates of the obesity–stroke association. The association between BMI and hemorrhagic stroke remains less clear. Preventing obesity may lead to a substantial reduction of total and ischemic stroke occurrence.
Acknowledgments
The study was supported by the National Institutes of Health (CA-47988 and HL-43851), Bethesda, Md. We are indebted to the participants in the Women’s Health Study for their outstanding commitment and cooperation, to the entire Women’s Health Study staff for their expert and unfailing assistance, and to Gregory Kotler for programming assistance.
References
The catastrophic failures of public health. Lancet. 2004; 363: 745.
Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its high toll. JAMA. 2003; 289: 229–230.
Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians. Arch Intern Med. 2004; 164: 249–258.
Centers for Disease Control and Prevention. Physical activity and good nutrition: essential elements to prevent chronic diseases and obesity 2004. Available at: http://www.cdc.gov/nccdphp/aag/pdf/aag_dnpa2004.pdf. Accessed October 30, 2004.
National Center for Health Statistic. Prevalence of overweight among children and adolescents: United States, 1999–2002. 2004. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm. Accessed November 4, 2004.
Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999; 282: 1530–1538.
National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2000; 160: 898–904.
National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. 1998. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed November 4, 2004.
Jood K, Jern C, Wilhelmsen L, Rosengren A. Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke. 2004; 35: 2764–2769.
Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, Buring JE, Manson JE. Body mass index and the risk of stroke in men. Arch Intern Med. 2002; 162: 2557–2562.
Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2003; 34: 1586–1592.
Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW, Speizer FE, Manson JE. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA. 1997; 277: 1539–1545.
Milionis HJ, Goudevenos J, Seferiadis K, Elisaf MS. Associations between body mass index and risks in elderly patients with a first-ever acute ischemic stroke. Arch Intern Med. 2003; 163: 980. Letter.
Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke. 2004; 35: 831–836.
Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001; 32: 280–299.
de Freitas GR, Bogousslavsky J. Primary stroke prevention. Eur J Neurol. 2001; 8: 1–15.
D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication: the Framingham Study. Stroke. 1994; 25: 40–43.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991; 22: 312–318.
Thrift AG, McNeil JJ, Forbes A, Donnan GA, for the Melbourne Risk Factor Study (MERFS) Group. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Stroke. 1996; 27: 2020–2025.
Rodriguez BL, D’Agostino R, Abbott RD, Kagan A, Burchfiel CM, Yano K, Ross GW, Silbershatz H, Higgins MW, Popper J, Wolf PA, Curb JD. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke. 2002; 33: 230–236.
Abbott RD, Behrens GR, Sharp DS, Rodriguez BL, Burchfiel CM, Ross GW, Yano K, Curb JD. Body mass index and thromboembolic stroke in nonsmoking men in older middle age: the Honolulu Heart Program. Stroke. 1994; 25: 2370–2376.
Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003; 34: 1106–1113.
Buring JE, Hennekens CH, for the Women’s Health Study Research Group. The Women’s Health Study: summary of the study design. J Myocardial Ischemia. 1992; 4: 27–29.
Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women’s Health Study. J Womens Health Gend Based Med. 2000; 9: 19–27.
Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke. 1981; 12: I13–I44.
Atiya M, Kurth T, Berger K, Buring JE, Kase CS. Interobserver agreement in the classification of stroke in the Women’s Health Study. Stroke. 2003; 34: 565–567.
Cox DR. Regression models and life-tables (with discussion). J Roy Stat Soc. 1972; 34: 187–220.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26- year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67: 968–977.
Lindenstrom E, Boysen G, Nyboe J. Risk factors for stroke in Copenhagen, Denmark, II: life-style factors. Neuroepidemiology. 1993; 12: 43–50.
Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990; 21: 701–706.
DiPietro L, Ostfeld AM, Rosner GL. Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study. Am J Public Health. 1994; 84: 14–19.
Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ. 1984; 289: 1257–1261.
Selmer R, Tverdal A. Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women. J Epidemiol Commun Health. 1995; 49: 265–270.
Shinton R, Shipley M, Rose G. Overweight and stroke in the Whitehall study. J Epidemiol Commun Health. 1991; 45: 138–142.
Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke. 1994; 25: 814–820.
Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol. 1996; 144: 1143–1150.
Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P. Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension. 2004; 43: 25–30.
Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, Gaziano JM. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004; 292: 1188–1194.
Gostynski M, Gutzwiller F, Kuulasmaa K, Doring A, Ferrario M, Grafnetter D, Pajak A. Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project. Int J Obes Relat Metab Disord. 2004; 28: 1082–1090.
Li C, Engstr;m G, Hedblad B, Berglund G, Janzon L. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke. 2005; 36: 234–238.
Shinton R, Sagar G, Beevers G. Body fat and stroke: unmasking the hazards of overweight and obesity. J Epidemiol Commun Health. 1995; 49: 259–264.
De Pergola G, De Mitrio V, Giorgino F, Sciaraffia M, Minenna A, Di Bari L, Pannacciulli N, Giorgino R. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord. 1997; 21: 527–535.
Morange PE, Alessi MC, Verdier M, Casanova D, Magalon G, Juhan-Vague I. PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level. Arterioscler Thromb Vasc Biol. 1999; 19: 1361–1365.
Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med. 2000; 32 (suppl 1): 78–84.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282: 2131–2135.
Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med. 1997; 336: 1014–1016.
Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001; 32: 917–924.
Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massero JM, D’Agostino RB, Franzblau C, Wilson PWF. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke. 2001; 11: 2575–2579.
Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983; 117: 651–658.(Tobias Kurth, MD, ScD; J.)
Division of Cardiovascular Disease (J.M.G.)
Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
Department of Epidemiology (T.K., N.R.C., J.E.M., J.E.B.)
Harvard School of Public Health
Massachusetts Veterans Epidemiology Research and Information Center (J.M.G.), Boston VA Healthcare System
Department of Ambulatory Care and Prevention (J.E.B.), Harvard Medical School
Department of Neurology (C.S.K.), Boston University Medical Center, Boston, Mass.
Abstract
Background— Obesity is an escalating pandemic in the United States, and its association with coronary heart disease is well understood. Several studies have found positive associations between body mass index (BMI) and stroke in men, but the association with stroke and its subtypes is less clear in women.
Methods and Results— This was a prospective cohort study among 39 053 women participating in the Women’s Health Study. BMI was measured as self-reported weight (in kilograms) divided by height (in meters) squared. Incident stroke was self-reported and confirmed by medical record review. We used the Cox proportional hazards model to evaluate the association between BMI and stroke. After a mean follow-up of 10 years, a total of 432 strokes (347 ischemic, 81 hemorrhagic, and 4 undefined) occurred. We found a statistically significant trend for increased risk of total and ischemic stroke across 7 BMI categories. With World Health Organization criteria, women who were obese (BMI 30 kg/m2) had hazard ratios of 1.50 (95% CI 1.16 to 1.94) for total stroke, 1.72 (95% CI 1.30 to 2.28) for ischemic stroke, and 0.82 (95% CI 0.43 to 1.58) for hemorrhagic stroke compared with women with BMI <25 kg/m2. Additional control for history of hypertension, diabetes, and elevated cholesterol substantially attenuated the hazard ratios for total and ischemic stroke. There was no effect modification for age, exercise, or smoking.
Conclusions— In this large prospective cohort study among women, BMI was a strong risk factor for total and ischemic stroke but not for hemorrhagic stroke. The association was highly mediated by hypertension, diabetes, and elevated cholesterol.
Key Words: obesity ; stroke ; epidemiology ; women
Introduction
Overweight and obesity represent an emerging threat to public health,1–3 affecting nearly 59 million adults in the United States alone.4 In addition, and perhaps more worrisome, the percentage of young people who are overweight has more than doubled over the last 20 years.4,5 Approximately 300 000 deaths each year in the United States are estimated to be attributable to obesity,6 and the economic burden is enormous.4 Overweight and obesity are well-documented risk factors for a variety of diseases,2 including coronary heart disease, hypertension, type 2 diabetes mellitus, osteoarthritis, and certain cancers.7,8
There is increasing evidence that obesity is a risk factor for ischemic stroke.9–14 Despite this, excess weight has not been recognized as an established risk factor for stroke15 and generally has not been included in the overall estimation of stroke risk.16–18 In addition, the association between body mass index (BMI) and hemorrhagic stroke is less clear.9,10,12,14,19–21 Stroke remains a leading cause of severe disability and premature death in the United States and other Western countries. Effective therapies for the treatment of acute ischemic stroke only are used in a small number of patients22 and do not help to completely reverse the impaired function of affected brain areas. Thus, the identification of modifiable lifestyle factors remains critical for stroke prevention. We aimed to evaluate the association between BMI and total stroke, ischemic stroke, and hemorrhagic stroke in more than 39 000 apparently healthy female health professionals participating in the Women’s Health Study (WHS).
Methods
Participants
Study individuals were all participants in the WHS, a recently completed randomized, double-blind, placebo-controlled trial that tested the benefits and risks of low-dose aspirin and vitamin E in the primary prevention of cardiovascular disease and cancer among apparently healthy women. The design and methods of the WHS have been described in detail previously.23,24 Briefly, a total of 39 876 US female health professionals aged 45 years or older at baseline in beginning of 1993 and without a history of cardiovascular disease, cancer, or other major illnesses were randomly assigned to 1 of 4 treatment groups: active aspirin (100 mg on alternate days), active vitamin E (600 IU on alternate days), both active agents, or both placebos. Baseline information was self-reported and was collected by a mailed questionnaire that asked about a large number of cardiovascular risk factors and lifestyle variables. Twice in the first year and annually thereafter, participants were sent follow-up questionnaires that asked about study compliance, study outcomes (including stroke), personal characteristics, medical history, and health habits during the study period. For the present analysis, we included follow-up information from the time of randomization through March 31, 2004. As of this date, follow-up was 96% complete. The Institutional Review Board of the Brigham and Women’s Hospital approved the study.
Assessment of BMI
Participants reported their height and weight on the baseline questionnaire. On the 24-, 36-, 60-, 72-, and 108-month questionnaires, participants were asked again to report their weight, and on the 72- and 108-month questionnaires, they were asked to report their height again. BMI was calculated as self-reported weight in kilograms divided by height in meters squared (kg/m2). We used the baseline height information to calculate BMI for all but the 72- and 108-month time points. We categorized BMI into a priori categories of <20.0, 20.0 to 22.9, 23.0 to 24.9, 25.0 to 26.9, 27.0 to 29.9, 30.0 to 34.9, and 35.0 kg/m2. We further evaluated BMI on the basis of the World Health Organization (WHO) categories of <25 (normal weight), 25 to 29.9 (overweight), and 30 kg/m2 (obese), as well as a continuous term.
Ascertainment of Stroke
Participants who reported a stroke on a follow-up questionnaire were asked for permission to review their medical records. A diagnosis of stroke was confirmed only after review of the medical records by an End Points Committee of physicians that included a neurologist. A nonfatal stroke was defined as a focal neurological deficit of sudden onset and vascular mechanism that lasted >24 hours. Cases of fatal stroke were documented by evidence of a cerebrovascular mechanism obtained from all available sources, including death certificates and hospital records. Stroke was classified according to the criteria established by the National Survey of Stroke25 as ischemic stroke, hemorrhagic stroke, and unknown subtype. The interobserver agreement of the classification of stroke and its major subtypes in the WHS was excellent.26
Statistical Analysis
Of the 39 876 randomized participants, we excluded 820 women with missing information on weight or height on the baseline questionnaire. We additionally excluded 3 participants who reported a stroke before the receipt of the baseline questionnaire, which left a total of 39 053 women for the present study.
We compared the characteristics of participants with respect to baseline BMI categories using direct standardization to adjust categorical variables for age in 5-year increments. We used the Cox proportional hazards model27 to analyze the association between BMI and the incidence of stroke. We calculated age- and multivariable-adjusted hazard ratios (HRs) and their 95% CIs for total (including ischemic, hemorrhagic, and undefined stroke cases), ischemic, and hemorrhagic (including subarachnoid and intracerebral hemorrhage) strokes. We made a distinction in the multivariable models between variables that were considered potential confounders and those considered potential biological intermediate variables in the association between BMI and stroke risk. In the first multivariable model (model 1), we controlled for age (quadratic term), alcohol consumption (<1 drink per week, 1 to 6 drinks per week, 1 drink per day), smoking (never, past, current <15 cigarettes per day, current 15 cigarettes per day), physical activity (1 time per week, 2 to 3 times per week, 4 times per week), and postmenopausal hormone use. We considered other potential confounding variables including ethnicity, oral contraceptive use, and education, which did not lead to substantially different results. We then considered 3 potential biological mediators: history of hypertension (defined as self-reported systolic blood pressure of 140 mm Hg or diastolic blood pressure 90 mm Hg, or report of diagnosis of hypertension by a physician), history of diabetes, and history of elevated cholesterol (240 mg/dL). In the second multivariable model (model 2), we controlled for all variables in model 1 plus hypertension at baseline. In the third model, we then additionally controlled for history of diabetes and elevated cholesterol at baseline. We decided a priori not to control for randomized treatment assignment. Because randomization in this large trial was successful,24 randomized treatment assignment is not associated with BMI. Consequently, by definition, randomized treatment assignment cannot be a confounder of the association between BMI and stroke.
Our primary analysis was to evaluate the association between baseline BMI and risk of total, ischemic, and hemorrhagic stroke. As a secondary approach, we updated the information on BMI by incorporating weight change over time. We evaluated effect modification by age (<60 versus 60 years), exercise frequency (<1 times per week versus 1 times per week), and smoking status (current versus never/past). We used the likelihood ratio test to test for statistical significance. All probability values were 2 tailed, and we considered P<0.05 as statistically significant.
Results
When we used WHO categories for BMI, women in the obese category (30 kg/m2) had multivariable-adjusted (model 1) HRs of 1.50 (95% CI 1.16 to 1.94) for total stroke, 1.72 (95% CI 1.30 to 2.28) for ischemic stroke, and 0.82 (95% CI 0.43 to 1.58) for hemorrhagic stroke compared with women with BMI <25 kg/m2. After we additionally controlled for history of hypertension, diabetes, and elevated cholesterol, the risks of total and ischemic stroke were attenuated to 1.04 (95% CI 0.80 to 1.37) for total stroke and 1.15 (95% CI 0.85 to 1.55) for ischemic stroke.
When we evaluated BMI as a continuous variable, a 1-unit increase in BMI was associated with a 4% increase in total stroke (multivariable [model 1]-adjusted HR 1.04, 95% CI 1.02 to 1.06) and a 5% increase for ischemic stroke (HR 1.05, 95% CI 1.03 to 1.07) but had no association with hemorrhagic stroke (HR 0.99, 95% CI 0.94 to 1.04). These relative risks for total and ischemic stroke were also attenuated after we controlled for history of hypertension, diabetes, and elevated cholesterol: 1.01 (95% CI 0.99 to 1.03) for total stroke and 1.02 (95% CI 0.99 to 1.04) for ischemic stroke.
When we updated the information on BMI over the course of follow-up, the results were similar in direction compared with the association between baseline BMI and risk of stroke and stroke subtypes. After adjustment for potential confounders (model 1), women with BMI values 35 kg/m2 had HRs of 1.66 (95% CI 1.01 to 2.71) for total stroke, 1.89 (95% CI 1.09 to 3.26) for ischemic stroke, and 0.79 (95% CI 0.23 to 2.65) for hemorrhagic stroke. As before, the HRs for total and ischemic stroke were attenuated when we additionally controlled for history of hypertension, diabetes, and elevated cholesterol, with HRs of 1.02 (95% CI 0.62 to 1.69) for total stroke and 1.10 (95% CI 0.63 to 1.94) for ischemic stroke.
Discussion
In this large prospective cohort study of >39 000 apparently healthy women, BMI was strongly associated with total and ischemic stroke but not with hemorrhagic stroke. We found a statistically significant trend across BMI categories for total and ischemic stroke and found significant increased risks for ischemic stroke beginning with BMI values 27.0 kg/m2 that steadily increased with higher BMI. Women with BMI 35 kg/m2 had a 2-fold increase in the risk of total stroke and an almost 3-fold increase in the risk of ischemic stroke compared with women with BMI <20 kg/m2. When WHO criteria were used, women who were obese (BMI 30 kg/m2) had a 1.5-fold increase in the risk of total stroke and a 1.7-fold increase in the risk of ischemic stroke compared with women with BMI <25 kg/m2. The association between BMI and total and ischemic stroke was strongly mediated by history of hypertension, diabetes, and elevated cholesterol. The association between BMI and stroke was not modified by age, smoking status, or exercise.
Over the last 2 decades, the association between obesity and stroke among women has been inconsistent, with some studies showing a positive association,11,12,28–30 and others showing no association.31–33 Data from the Nurses’ Health Study showed similar associations as in the present study and found a >2-fold increase in the risk of ischemic stroke and 1.6-fold increase in the risk for total stroke among women with BMI 32 kg/m2 compared with women with BMI <21 kg/m2.12 As in the present study, inclusion of hypertension, diabetes, and elevated cholesterol led to substantial attenuation of the risk estimates. There was also a suggestion of an inverse association between BMI and hemorrhagic stroke that also did not reach statistical significance. Similar to the present findings, the highest risk for hemorrhagic stroke was seen among women in the leanest BMI category. The study further evaluated weight change and found increased risk for total and ischemic stroke but not for hemorrhagic stroke among women who gained >11 kg.12 Studies that found no association between obesity and stroke may have been limited by small size32 or may have controlled for the potential biological mediator of hypertension.31,33
In men, a number of studies support an association between BMI and increased risk of stroke.9,10,21,34 A recent population-based study from G;teborg, Sweden, found a 2-fold increase in the risk for total, ischemic, and undetermined stroke for men with BMI >30 kg/m2 compared with men with BMI of 20.0 to 22.5 kg/m2.9 No association was observed between BMI and hemorrhagic stroke. Because that study showed a strong association between BMI and undetermined stroke, it is possible that some of these cases were in fact hemorrhagic strokes and that the association between BMI and hemorrhagic stroke was thus underestimated. Data from the Physicians’ Health Study showed a significant increase in the risk of total, ischemic, and hemorrhagic stroke with increasing BMI.10 Men with BMI 30 kg/m2 had a >2-fold risk increase for all stroke types. In both studies, the increased risk for total and ischemic stroke, although attenuated, remained statistically significant when additionally controlled for hypertension, diabetes, and elevated cholesterol.
The association between obesity and hemorrhagic stroke remains unclear. The present study is consistent with findings of others that showed an increased risk of hemorrhagic stroke among the lean.12,14,19 Other studies, however, found no association9,20,21 or an increased risk with increasing BMI.10 The fact that the incidence of hemorrhagic stroke is higher in Asian populations has led to the hypothesis that low cholesterol, in addition to lean body weight, may be associated with increased risk of hemorrhagic strokes.20,35 The low numbers of hemorrhagic strokes in most of the studies may explain in part the uncertainty with regard to the association between BMI and hemorrhagic stroke. Future studies are needed to determine whether lean BMI and/or low cholesterol or other factors are important contributors to hemorrhagic stroke.
There is an ongoing discussion about the best measure of obesity for stroke prediction.11,30,32,36 A report from the Northern Manhattan Stroke Study suggested that abdominal obesity, as measured by the waist-to-hip ratio, was a stronger predictor than BMI and had a greater effect among younger individuals.11 In that study, however, obesity was evaluated at the time of the stroke, which may indicate that abdominal obesity may be a better short-term predictor than BMI. Nevertheless, obesity is a strong risk factor for total and ischemic stroke regardless of the measure used. Whether more detailed information on body fat distribution will lead to better prediction of stroke currently remains unclear.
Obesity is a strong risk factor for the development of hypertension,37 diabetes,38 and elevated cholesterol.39 In virtually all studies that have evaluated the association between obesity and ischemic stroke, hypertension, diabetes, and elevated cholesterol were biological mediators.9,10,12,14,36 This, however, should not downplay the importance of obesity as a primary risk factor for stroke. To the contrary, because obesity has such a strong influence on hypertension and diabetes, obesity may be the biggest overall contributor to stroke occurrence. In some studies, a statistically significant excess risk for stroke remained even after controlling for hypertension, diabetes, and elevated cholesterol.9–11 In a recent large, population-based study from Malm;, Sweden among normotensive men and women, BMI was a statistically significant and independent predictor for stroke.40 Furthermore, the risks of excessive body fat for stroke can be obscured by a history of cigarette smoking and thinness associated with deteriorating health.41
In addition to the established mechanisms by which BMI affects stroke risk such as hypertension and diabetes, other mechanisms may be associated with the increased risk. Some investigators have proposed that an increase in prothrombotic factors observed among overweight and obese individuals may contribute to their increased risk for ischemic events.42–44 Increased levels of C-reactive protein in overweight and obese individuals45 may also play a role in their increased risk of stroke,46 because an association between increased levels of inflammatory markers and risk of ischemic stroke has been documented47,48; however, the biological interrelationship between obesity, inflammatory markers, and ischemic stroke risk has yet to be determined.
The present study has several strengths, including the prospective method of data collection, the large size of the study population, the large number of incident strokes, the high rate and length of follow-up, and the homogeneous nature of WHS participants, which reduces potential confounding by access to medical care and other socioeconomic factors. On each of the follow-up questionnaires, WHS participants were asked specifically about stroke and transient ischemic attacks. Because stroke was a major end point of the WHS trial, all efforts were made to obtain the relevant medical records, and an experienced End Points Committee confirmed stroke cases only after review of these records. In addition, the interobserver agreement in the classification of stroke was excellent.26 We further ran several different models, including time-varying models, to update the most recent exposure information, used different cutpoints of BMI, and evaluated potential biological mediators and effect modifiers.
Several limitations should be considered when evaluating the present results. First, information on body weight and height, as well as on all potential confounders, was self-reported, and thus nondifferential misclassification is possible. Participants of the WHS, however, were all health professionals, who are known to accurately report information regarding lifestyle factors and health status. Specifically, self-reported and directed measured weight were highly correlated (r=0.96) in another comparable cohort of female health professionals.49 In addition, nondifferential misclassification in a prospective study most likely would lead to an underestimation of the association between BMI and stroke. We have no reason to believe that a significant number of participants did not report a stroke event and particularly no reasoning that such potential underreporting would be differential with regard to BMI status. Second, because participants in the WHS were all health professionals who participated in a randomized trial, and the vast majority (94.9%) of them were white, the present results may not necessarily be extrapolated to other populations; however, we have no a priori basis for believing that the biological mechanisms by which BMI may lead to stroke differ in the WHS cohort compared with other populations. In addition, the relative measures of effect for a wide variety of cardiovascular risk factors have been similar to those seen in other studies. Because women participating in the WHS were somewhat leaner than the general population, we may have underestimated the risk of heavier populations. Finally, as with all observational studies, residual and unmeasured confounding remains an alternative explanation for our findings, despite adjustment for many potential confounders.
In conclusion, our study indicates that obesity is associated with increased risk of total and ischemic stroke. This was not modified by age, smoking, or exercise and was strongly mediated by hypertension, diabetes, and elevated cholesterol, which may be biological intermediates of the obesity–stroke association. The association between BMI and hemorrhagic stroke remains less clear. Preventing obesity may lead to a substantial reduction of total and ischemic stroke occurrence.
Acknowledgments
The study was supported by the National Institutes of Health (CA-47988 and HL-43851), Bethesda, Md. We are indebted to the participants in the Women’s Health Study for their outstanding commitment and cooperation, to the entire Women’s Health Study staff for their expert and unfailing assistance, and to Gregory Kotler for programming assistance.
References
The catastrophic failures of public health. Lancet. 2004; 363: 745.
Manson JE, Bassuk SS. Obesity in the United States: a fresh look at its high toll. JAMA. 2003; 289: 229–230.
Manson JE, Skerrett PJ, Greenland P, VanItallie TB. The escalating pandemics of obesity and sedentary lifestyle: a call to action for clinicians. Arch Intern Med. 2004; 164: 249–258.
Centers for Disease Control and Prevention. Physical activity and good nutrition: essential elements to prevent chronic diseases and obesity 2004. Available at: http://www.cdc.gov/nccdphp/aag/pdf/aag_dnpa2004.pdf. Accessed October 30, 2004.
National Center for Health Statistic. Prevalence of overweight among children and adolescents: United States, 1999–2002. 2004. Available at: http://www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm. Accessed November 4, 2004.
Allison DB, Fontaine KR, Manson JE, Stevens J, VanItallie TB. Annual deaths attributable to obesity in the United States. JAMA. 1999; 282: 1530–1538.
National Task Force on the Prevention and Treatment of Obesity. Overweight, obesity, and health risk. Arch Intern Med. 2000; 160: 898–904.
National Heart, Lung, and Blood Institute. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults. 1998. Available at: http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed November 4, 2004.
Jood K, Jern C, Wilhelmsen L, Rosengren A. Body mass index in mid-life is associated with a first stroke in men: a prospective population study over 28 years. Stroke. 2004; 35: 2764–2769.
Kurth T, Gaziano JM, Berger K, Kase CS, Rexrode KM, Cook NR, Buring JE, Manson JE. Body mass index and the risk of stroke in men. Arch Intern Med. 2002; 162: 2557–2562.
Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC. Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke. 2003; 34: 1586–1592.
Rexrode KM, Hennekens CH, Willett WC, Colditz GA, Stampfer MJ, Rich-Edwards JW, Speizer FE, Manson JE. A prospective study of body mass index, weight change, and risk of stroke in women. JAMA. 1997; 277: 1539–1545.
Milionis HJ, Goudevenos J, Seferiadis K, Elisaf MS. Associations between body mass index and risks in elderly patients with a first-ever acute ischemic stroke. Arch Intern Med. 2003; 163: 980. Letter.
Song YM, Sung J, Davey Smith G, Ebrahim S. Body mass index and ischemic and hemorrhagic stroke: a prospective study in Korean men. Stroke. 2004; 35: 831–836.
Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard G, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, del Zoppo GJ. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke. 2001; 32: 280–299.
de Freitas GR, Bogousslavsky J. Primary stroke prevention. Eur J Neurol. 2001; 8: 1–15.
D’Agostino RB, Wolf PA, Belanger AJ, Kannel WB. Stroke risk profile: adjustment for antihypertensive medication: the Framingham Study. Stroke. 1994; 25: 40–43.
Wolf PA, D’Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991; 22: 312–318.
Thrift AG, McNeil JJ, Forbes A, Donnan GA, for the Melbourne Risk Factor Study (MERFS) Group. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Stroke. 1996; 27: 2020–2025.
Rodriguez BL, D’Agostino R, Abbott RD, Kagan A, Burchfiel CM, Yano K, Ross GW, Silbershatz H, Higgins MW, Popper J, Wolf PA, Curb JD. Risk of hospitalized stroke in men enrolled in the Honolulu Heart Program and the Framingham Study: a comparison of incidence and risk factor effects. Stroke. 2002; 33: 230–236.
Abbott RD, Behrens GR, Sharp DS, Rodriguez BL, Burchfiel CM, Ross GW, Yano K, Curb JD. Body mass index and thromboembolic stroke in nonsmoking men in older middle age: the Honolulu Heart Program. Stroke. 1994; 25: 2370–2376.
Heuschmann PU, Berger K, Misselwitz B, Hermanek P, Leffmann C, Adelmann M, Buecker-Nott HJ, Rother J, Neundoerfer B, Kolominsky-Rabas PL. Frequency of thrombolytic therapy in patients with acute ischemic stroke and the risk of in-hospital mortality: the German Stroke Registers Study Group. Stroke. 2003; 34: 1106–1113.
Buring JE, Hennekens CH, for the Women’s Health Study Research Group. The Women’s Health Study: summary of the study design. J Myocardial Ischemia. 1992; 4: 27–29.
Rexrode KM, Lee IM, Cook NR, Hennekens CH, Buring JE. Baseline characteristics of participants in the Women’s Health Study. J Womens Health Gend Based Med. 2000; 9: 19–27.
Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke: clinical findings. Stroke. 1981; 12: I13–I44.
Atiya M, Kurth T, Berger K, Buring JE, Kase CS. Interobserver agreement in the classification of stroke in the Women’s Health Study. Stroke. 2003; 34: 565–567.
Cox DR. Regression models and life-tables (with discussion). J Roy Stat Soc. 1972; 34: 187–220.
Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: a 26- year follow-up of participants in the Framingham Heart Study. Circulation. 1983; 67: 968–977.
Lindenstrom E, Boysen G, Nyboe J. Risk factors for stroke in Copenhagen, Denmark, II: life-style factors. Neuroepidemiology. 1993; 12: 43–50.
Folsom AR, Prineas RJ, Kaye SA, Munger RG. Incidence of hypertension and stroke in relation to body fat distribution and other risk factors in older women. Stroke. 1990; 21: 701–706.
DiPietro L, Ostfeld AM, Rosner GL. Adiposity and stroke among older adults of low socioeconomic status: the Chicago Stroke Study. Am J Public Health. 1994; 84: 14–19.
Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjostrom L. Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. BMJ. 1984; 289: 1257–1261.
Selmer R, Tverdal A. Body mass index and cardiovascular mortality at different levels of blood pressure: a prospective study of Norwegian men and women. J Epidemiol Commun Health. 1995; 49: 265–270.
Shinton R, Shipley M, Rose G. Overweight and stroke in the Whitehall study. J Epidemiol Commun Health. 1991; 45: 138–142.
Benfante R, Yano K, Hwang LJ, Curb JD, Kagan A, Ross W. Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men: implications of shared risk. Stroke. 1994; 25: 814–820.
Walker SP, Rimm EB, Ascherio A, Kawachi I, Stampfer MJ, Willett WC. Body size and fat distribution as predictors of stroke among US men. Am J Epidemiol. 1996; 144: 1143–1150.
Hu G, Barengo NC, Tuomilehto J, Lakka TA, Nissinen A, Jousilahti P. Relationship of physical activity and body mass index to the risk of hypertension: a prospective study in Finland. Hypertension. 2004; 43: 25–30.
Weinstein AR, Sesso HD, Lee IM, Cook NR, Manson JE, Buring JE, Gaziano JM. Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA. 2004; 292: 1188–1194.
Gostynski M, Gutzwiller F, Kuulasmaa K, Doring A, Ferrario M, Grafnetter D, Pajak A. Analysis of the relationship between total cholesterol, age, body mass index among males and females in the WHO MONICA Project. Int J Obes Relat Metab Disord. 2004; 28: 1082–1090.
Li C, Engstr;m G, Hedblad B, Berglund G, Janzon L. Risk factors for stroke in subjects with normal blood pressure: a prospective cohort study. Stroke. 2005; 36: 234–238.
Shinton R, Sagar G, Beevers G. Body fat and stroke: unmasking the hazards of overweight and obesity. J Epidemiol Commun Health. 1995; 49: 259–264.
De Pergola G, De Mitrio V, Giorgino F, Sciaraffia M, Minenna A, Di Bari L, Pannacciulli N, Giorgino R. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution. Int J Obes Relat Metab Disord. 1997; 21: 527–535.
Morange PE, Alessi MC, Verdier M, Casanova D, Magalon G, Juhan-Vague I. PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level. Arterioscler Thromb Vasc Biol. 1999; 19: 1361–1365.
Juhan-Vague I, Alessi MC, Morange PE. Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity. Ann Med. 2000; 32 (suppl 1): 78–84.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282: 2131–2135.
Maseri A. Inflammation, atherosclerosis, and ischemic events: exploring the hidden side of the moon. N Engl J Med. 1997; 336: 1014–1016.
Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke. 2001; 32: 917–924.
Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, Massero JM, D’Agostino RB, Franzblau C, Wilson PWF. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham Study. Stroke. 2001; 11: 2575–2579.
Willett W, Stampfer MJ, Bain C, Lipnick R, Speizer FE, Rosner B, Cramer D, Hennekens CH. Cigarette smoking, relative weight, and menopause. Am J Epidemiol. 1983; 117: 651–658.(Tobias Kurth, MD, ScD; J.)